CENGİZ SEVAL, G. Et Al. 2023. Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .

CENGİZ SEVAL, G., DALVA, K., Bakanay, S. M., Soydan, E., İLHAN, O., BEKSAÇ, M., ... SÖNMEZ, G. M.(2023). Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .

CENGİZ SEVAL, GÜLDANE Et Al. "Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023

CENGİZ SEVAL, GÜLDANE C. Et Al. "Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023

CENGİZ SEVAL, G. Et Al. (2023) . "Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .

@article{article, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2023}